SCHEMBL7419745

SCHEMBL7419745

CCCCOc1ccc(S(=O)(=O)NC(CC(=O)NO)c2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 5/20 0.59
MMP13 P45452 4/20 0.59
MMP2 P08253 3/20 0.59
ADAMTS4 O75173 1/20 0.59
MMP14 P50281 1/20 0.59
ADAMTS5 Q9UNA0 1/20 0.59
ALDH1A1 P00352 3/20 0.55
ATM Q13315 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
MMP3 P08254 5/20 0.54
EEF2K O00418 2/20 0.51
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
KCNA5 P22460 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
GPR88 Q9GZN0 1/20 0.48
FAAH O00519 1/20 0.47
MMP7 P09237 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410702 0.86 PDE4A (0.67) MMP1MMP2ALDH1A1ATML3MBTL1
SCHEMBL7411095 0.82 MMP1 (0.65) MMP1MMP13MMP2ADAMTS4MMP14
SCHEMBL7464069 0.81 MMP1 (0.64) MMP1MMP13MMP2ADAMTS4MMP14
SCHEMBL7418486 0.81 ATM (0.57) MMP1MMP13MMP2MMP14ALDH1A1
SCHEMBL2454202 0.81 MMP9 (0.58) MMP1MMP13MMP2ADAMTS4MMP14
SCHEMBL7420446 0.76 MMP1 (0.70) MMP1MMP13MMP2ADAMTS4MMP14
SCHEMBL8108648 0.76 MMP1 (0.70) MMP1MMP13MMP2ADAMTS4MMP14
SCHEMBL7419743 0.76 MMP2 (0.69) MMP1MMP13MMP2ADAMTS4MMP14
SCHEMBL7417303 0.75 MMP1 (0.68) MMP1MMP13MMP2ADAMTS4MMP14
SCHEMBL1287475 0.74 MAPT (0.58) MMP1MMP13MMP2MMP14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed